Latest Expansion Plans News

BWP Group has reported a 3% rise in revenue to $103.6 million for the half-year ending December 2025, driven by rental growth and strategic acquisitions. The internalisation of management has reduced fees and positioned the group for future growth.

Cobre Limited has had its trading suspension lifted immediately following the announcement of a significant acquisition and capital placement, signalling a pivotal moment for the base metals miner.

Cobre Limited has secured A$60 million to acquire a majority stake in the Sierra Atacama Copper Project in Chile, positioning itself as a significant copper producer with strong expansion potential.

International Graphite Limited has reported pilot-scale testwork results exceeding purity targets for expandable graphite, underpinning plans for a European production facility.

Tamboran Resources has appointed Todd Abbott as CEO and made significant progress in drilling and infrastructure development in the Beetaloo Basin, aiming for first gas sales in the third quarter of 2026.

Lindian Resources has launched a significant Stage 2 drilling program at its Kangankunde Rare Earths Project in Malawi, aiming to upgrade resource confidence and expand production capacity. The initiative targets converting up to 40 million tonnes of inferred resources to indicated status, underpinning plans to increase ore throughput and monazite concentrate output.

Talga Group has lodged a detailed prospectus for issuing attaching and piggyback options to recent Placement and Share Purchase Plan participants, potentially raising up to A$32.7 million upon exercise. The move supports its battery anode production scale-up and international expansion plans.

Wellnex Life Limited is exploring acquisition interest and convertible note funding to accelerate Pain Away's expansion and strengthen its financial footing, signaling a pivotal phase in its turnaround journey.

Locksley Resources has identified the Beefeater Shear, a significant new structural corridor at its Mojave Project, promising to expand high-grade antimony targets. Detailed underground mapping at the Desert Antimony Mine reveals fresh opportunities for resource growth.

Epsilon Healthcare’s subsidiary, Epsilon Pharma, has signed a three-year manufacturing agreement with New Zealand’s Puro to supply medicinal cannabis products to the UK and Europe, marking a significant step in its international expansion.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.